Interpretation of Human Epidermal Growth Factor Receptor 2 (HER2) In Situ Hybridization Assays Using 2013 Update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines

被引：14

作者：

Bhargava, Rohit ^{[1
]}

Dabbs, David J. ^{[1
]}

机构：

[1] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Pittsburgh, PA 15260 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 17期

关键词：

RECOMMENDATIONS; TRASTUZUMAB;

D O I：

10.1200/JCO.2013.53.9213

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1855 / 1855

页数：1

共 50 条

[21] The human epidermal growth factor receptor 2 (HER2)
Tafe, Laura J.
Tsongalis, Gregory J.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
[22] Impact of the new American society of clinical oncology (ASCO)/college of American pathologists (CAP) guidelines on the determination of breast cancer HER2 status
Gilmore, H. L.
Collins, L. C.
Connolly, J. L.
Schmitt, S. J.
MODERN PATHOLOGY, 2008, 21 : 32A - 33A
[23] Impact of the new American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines on the determination of breast cancer HER2 status
Gilmore, H. L.
Collins, L. C.
Connolly, J. L.
Schnitt, S. J.
LABORATORY INVESTIGATION, 2008, 88 : 32A - 33A
[24] The 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for HER2 Testing in Breast Cancer increases the requirement for Reflex In Situ Hybridisation Testing
Tchrakian, N.
Flanagan, L.
Harford, J.
Gannon, J.
Quinn, C.
JOURNAL OF PATHOLOGY, 2015, 237 : S32 - S32
[25] Comparative analysis of human epidermal growth factor receptor 2 (HER2) testing in breast cancer according to 2007 and 2013 American Society of Clinical Oncology / College of American Pathologist guideline recommendations (ASCO/CAP)
Wernicke, A.
De la Iglesia, P.
Garcia Rivello, H.
VIRCHOWS ARCHIV, 2018, 473 : S31 - S31
[26] Laboratory Compliance With the American Society of Clinical Oncology/College of American Pathologists Guidelines for Human Epidermal Growth Factor Receptor 2 Testing A College of American Pathologists Survey of 757 Laboratories
Nakhleh, Raouf E.
Grimm, Erin E.
Idowu, Michael O.
Souers, Rhona J.
Fitzgibbons, Patrick L.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (05) : 728 - 734
[27] Impact of 2013 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines on HER2 fluorescent in situ hybridization (FISH) testing in breast cancers: Experience from a national reference laboratory.
Johnson, Eric
Gulbahce, Evin H.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[28] Impact of the Updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) Guidelines on HER2 Test in Breast Cancer: Comparison of 2007, 2013 and 2018 Recommendations
Kim, Min Chong
Bae, Young Kyung
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 191 - 192
[29] The effect of the 2013 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines in HER2 positivity rates among women with breast cancer in SEER registries
Wang, X. K.
Hu, N.
Herget, K.
Cinbis, B. R.
Gulbahce, E. H.
CANCER RESEARCH, 2019, 79 (04)
[30] Impact of the Updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) Guidelines on HER2 Test in Breast Cancer: Comparison of 2007, 2013 and 2018 Recommendations
Kim, Min Chong
Bae, Young Kyung
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 191 - 192

← 1 2 3 4 5 →